Abstract
Chromosome 15q13q14 harbours the gene for the 7 nicotinic acetylcholine receptor subunit (CHRNA7) and a related gene (CHRFAM7A) which arises from a partly duplicated portion of CHRNA7. Recent evidence suggests that CHRFAM7A is a locus with a possible role in schizophrenia and cognitive functioning. We studied an antisaccade task as a fronto-parietal measure of executive function that reflects risk for schizophrenia. Association of CHRFAM7A genotype with antisaccade performance was assessed in 103 healthy Caucasian individuals. No significant associations of 2-bp deletion or CHRFAM7A copy number with antisaccade performance parameters were observed. The failure to observe an association between antisaccade performance and polymorphisms in CHRFAM7A gene is consistent with specificity of the gene effects on hippocampal and memory functions as previously demonstrated. Copyright © 2009 CINP.
Author supplied keywords
Cite
CITATION STYLE
Petrovsky, N., Schmechtig, A., Flomen, R. H., Kumari, V., Collier, D., Makoff, A., … Ettinger, U. (2009). CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance. International Journal of Neuropsychopharmacology, 12(2), 267–273. https://doi.org/10.1017/S1461145708009784
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.